Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spontaneous rhythmic movement and heart coherence assessment in children with ADHD during psychometric testing and group analytic music therapy
2010-019863-12Phase 3
- Sponsor
- Paris Descartes University
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Paris Descartes University. Primary endpoints: Specific components in movement style and Sequential neuropsychological processing level.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2010-019863-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019863-12.